Advertisement

Apoptosis

, Volume 15, Issue 4, pp 499–510 | Cite as

Gender differences in apoptotic signaling in heart failure due to volume overload

  • Melissa R. Dent
  • Paramjit S. Tappia
  • Naranjan S. DhallaEmail author
Original Paper

Abstract

This study examined sex differences in the regulation of pro- and anti-apoptotic proteins in cardiac hypertrophy and heart failure due to volume overload induced by arteriovenous (AV) shunt in rats. General characteristics and hemodynamic assessment revealed the presence of cardiac hypertrophy at 4 weeks of AV shunt in male (n = 12) and female (n = 12) rats, whereas heart failure was seen at 16 weeks in male rats only. Although a decrease in apoptosis was seen in hearts of both sexes at 4 weeks, an increase in apoptosis in males and a reduction in the female heart were observed at 16 weeks of AV shunt. Unlike females, increases in the pro-apoptotic proteins, BAX, caspases 3 and 9 were seen in 16 weeks post-AV shunt in male rats. While an increase in phospho-Bad was detected, phospho-Bcl-2 protein was decreased in males. Females showed an increase in only phospho-Bcl-2 protein at 16 weeks post-AV shunt. Ovariectomy (n = 12) abolished the increase in phospho-Bcl-2 protein, but this was restored by treatment with 17-β estradiol. These data suggest that downregulation of phospho-Bcl-2 and an upregulation of BAX may play a major role in cardiomyocyte apoptosis in heart failure due to volume overload in male rats. Furthermore, upregulation of phospho-Bcl-2 in the heart due to estrogen may confer resistance against cardiomyocyte apoptosis in females.

Keywords

Gender differences Volume overload Apoptosis Congestive heart failure 

Notes

Acknowledgments

This work was supported by a grant from the Canadian Institutes for Health Research. The infrastructural support for this project was provided by the St. Boniface Hospital Research Foundation. MRD was a predoctoral fellow of the Heart and Stroke Foundation of Canada.

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

  1. 1.
    Baldi A, Abbate A, Bussani R et al (2002) Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 34:165–174. doi: 10.1006/jmcc.2001.1498 CrossRefPubMedGoogle Scholar
  2. 2.
    Bing OH (1994) Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol 26:943–948. doi: 10.1006/jmcc.1994.1115 CrossRefPubMedGoogle Scholar
  3. 3.
    Cesselli D, Jakoniuk I, Barlucchi L et al (2001) Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89:279–286. doi: 10.1161/hh1501.094115 CrossRefPubMedGoogle Scholar
  4. 4.
    Cheng W, Kajstura J, Nitahara JA et al (1996) Programmed cell death affects the viable myocardium after infarction in rats. Exp Cell Res 226:316–327. doi: 10.1006/excr.1996.0232 CrossRefPubMedGoogle Scholar
  5. 5.
    Condorelli G, Morisco C, Stassi G et al (1999) Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. Circulation 99:3071–3078PubMedGoogle Scholar
  6. 6.
    Narula J, Haider N, Virmani R et al (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182–1189CrossRefPubMedGoogle Scholar
  7. 7.
    Olivetti G, Abbi R, Quaini F et al (1997) Apoptosis in the failing human. N Engl J Med 336:1131–1141CrossRefPubMedGoogle Scholar
  8. 8.
    Ren J (2007) Influence of gender on oxidative stress, lipid peroxidation, protein damage and apoptosis in hearts and brains from spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 34:432–438. doi: 10.1111/j.1440-1681.2007.04591.x CrossRefPubMedGoogle Scholar
  9. 9.
    Meldrum DR, Wang M, Tsai BM et al (2005) Intracellular signaling mechanisms of sex hormones in acute myocardial inflammation and injury. Front Biosci 10:1835–1867. doi: 10.2741/1665 CrossRefPubMedGoogle Scholar
  10. 10.
    Dent MR, Das S, Dhalla NS (2007) Alterations in both death and survival signals for apoptosis in heart failure due to volume overload. J Mol Cell Cardiol 43:726–732. doi: 10.1016/j.yjmcc.2007.09.001 CrossRefPubMedGoogle Scholar
  11. 11.
    Regula KM, Kirshenbaum LA (2005) Apoptosis of ventricular myocytes: a means to an end. J Mol Cell Cardiol 38:3–13. doi: 10.1016/j.yjmcc.2004.11.003 CrossRefPubMedGoogle Scholar
  12. 12.
    Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6:513–519. doi: 10.1038/74994 CrossRefPubMedGoogle Scholar
  13. 13.
    Wei MC, Zong WX, Cheng EH et al (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:624–626. doi: 10.1126/science.1059108 CrossRefGoogle Scholar
  14. 14.
    Pavlov EV, Priault M, Pietkiewicz D et al (2001) A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J Cell Biol 155:725–731. doi: 10.1083/jcb.200107057 CrossRefPubMedGoogle Scholar
  15. 15.
    Saito M, Korsmeyer SJ, Schlesinger PH (2000) BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat Cell Biol 2:553–555. doi: 10.1038/35019596 CrossRefPubMedGoogle Scholar
  16. 16.
    Murphy E, Imahashi K, Steenbergen C (2005) Bcl-2 regulation of mitochondrial energetics. Trends Cardiovasc Med 15:283–290. doi: 10.1016/j.tcm.2005.09.002 CrossRefPubMedGoogle Scholar
  17. 17.
    Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481–490. doi: 10.1016/S0092-8674(00)81589-5 CrossRefPubMedGoogle Scholar
  18. 18.
    Hayward CS, Kelly RP, Collins P (2000) The roles of gender, menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46:28–49. doi: 10.1016/S0008-6363(00)00005-5 CrossRefPubMedGoogle Scholar
  19. 19.
    Sugden PH, Clerk A (2001) Akt like a women: gender differences in susceptibility to cardiovascular disease. Circ Res 88:975–977. doi: 10.1161/hh1001.091864 CrossRefPubMedGoogle Scholar
  20. 20.
    Nekooeian AA, Pang CCY (2000) Effects of estrogen on venous function in rats with chronic heart failure. Am J Physiol Heart Circ Physiol 278:H1941–H1947PubMedGoogle Scholar
  21. 21.
    Dent MR, Dhalla NS, Tappia PS (2004) Phospholipase C gene expression, protein contents and activities in cardiac hypertrophy and heart failure due to volume overlaod. Am J Physiol Heart Circ Physiol 287:H719–H727. doi: 10.1152/ajpheart.01107.2003 CrossRefPubMedGoogle Scholar
  22. 22.
    Brower GL, Gardner JD, Janicki JS (2003) Gender mediated cardiac protection from adverse ventricular remodeling is abolished by ovariectomy. Mol Cell Biochem 251:89–95. doi: 10.1023/A:1025438000942 CrossRefPubMedGoogle Scholar
  23. 23.
    Gardner JD, Brower GL, Voloshenyuk TG, Janicki JS (2008) Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens. Am J Physiol Heart Circ Physiol 294:H198–H204. doi: 10.1152/ajpheart.00281.2007 CrossRefPubMedGoogle Scholar
  24. 24.
    Guerra S, Leri A, Wang X et al (1999) Myocyte death in the failing human heart is gender dependent. Circ Res 85:856–866PubMedGoogle Scholar
  25. 25.
    Zhang XP, Vatner SF, Shen YT et al (2007) Increased apoptosis and myocyte enlargement with decreased cardiac mass; distinctive features of the aging male, but not female, monkey heart. J Mol Cell Cardiol 43:487–491. doi: 10.1016/j.yjmcc.2007.07.048 CrossRefPubMedGoogle Scholar
  26. 26.
    Mallat Z, Fornes P, Costagliola R et al (2001) Age and gender effects on cardiomyocyte apoptosis in the normal human heart. J Gerontol A Biol Sci Med Sci 56:M719–M723PubMedGoogle Scholar
  27. 27.
    Wolf BB, Green DR (1999) Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem 274:20049–20052. doi: 10.1074/jbc.274.29.20049 CrossRefPubMedGoogle Scholar
  28. 28.
    Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1–6CrossRefPubMedGoogle Scholar
  29. 29.
    Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–619. doi: 10.1016/0092-8674(93)90509-O CrossRefPubMedGoogle Scholar
  30. 30.
    Xu J, Lu XW, Huang Y, Zhu PL, Li J (2009) Synergism of simvastatin with losartan prevents angiotensin II-induced cardiomyocyte apoptosis in vitro. J Pharm Pharmacol 61:503–510. doi: 10.1211/jpp/61.04.0013 CrossRefPubMedGoogle Scholar
  31. 31.
    Camper-Kirby D, Welch S, Walker A et al (2001) Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res 88:1020–1027. doi: 10.1161/hh1001.090858 CrossRefPubMedGoogle Scholar
  32. 32.
    Bae S, Zhang L (2005) Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J Pharmacol Exp Therap 315:1125–1135. doi: 10.1124/jpet.105.090803 CrossRefGoogle Scholar
  33. 33.
    Moorjani N, Westaby S, Narula J et al (2009) Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure. Am J Cardiol 103:1261–1268. doi: 10.1016/j.amjcard.2009.01.013 CrossRefPubMedGoogle Scholar
  34. 34.
    Aranguiz-Urroz P, Soto D, Contreras A et al (2009) Differential participation of angiotensin II type 1 and 2 receptors in the regulation of cardiac cell death triggered by angiotensin II. Am J Hypertens 22:569–576. doi: 10.1038/ajh.2009.32 CrossRefPubMedGoogle Scholar
  35. 35.
    Fabris B, Candido R, Bortoletto M et al (2007) Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes. J Hypertens 25:1481–1490. doi: 10.1097/HJH.0b013e328121aae7 CrossRefPubMedGoogle Scholar
  36. 36.
    Anversa P, Leri A, Beltrami CA, Geurra S, Kajstura J (1998) Myocyte death and growth in the failing heart. Lab Invest 78:767–786PubMedGoogle Scholar
  37. 37.
    Communal C, Colucci WS (2005) The control of cardiomyocyte apoptosis via the β-adrenergic signaling pathways. Arch Mal Coeur Vaiss 98:236–241PubMedGoogle Scholar
  38. 38.
    Richards RG, DiAugustine RP, Petrusz P, Clark GC, Sebastian J (1996) Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in uterus. Proc Natl Acad Sci USA 93:12002–12007CrossRefPubMedGoogle Scholar
  39. 39.
    Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13:2905–2927CrossRefPubMedGoogle Scholar
  40. 40.
    Van Eickels M, Grohe C, Cleutjens JP, Janssen BJ, Wellens HJ, Doevendans PA (2001) 17 β-estradiol attenuates the development of pressure-overload hypertrophy. Circulation 104:1419–1423. doi: 10.1161/hc3601.095577 CrossRefPubMedGoogle Scholar
  41. 41.
    Patten RD, Pourati I, Aronovitz MJ (2004) 17β-estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 95:692–699. doi: 10.1161/01.RES.0000144126.57786.89 CrossRefPubMedGoogle Scholar
  42. 42.
    Satoh M, Matter CM, Ogita H et al (2007) Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 115:3197–3204. doi: 10.1161/CIRCULATIONAHA.106.657981 CrossRefPubMedGoogle Scholar
  43. 43.
    Wang M, Wang Y, Weil B et al (2009) Estrogen receptor β mediates increased activation of PI3 K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am J Physiol Reg Integr Comp Physiol 296:R972–R978. doi: 10.1152/ajpregu.00045.2009 Google Scholar
  44. 44.
    Biondi-Zoccai GG, Baldi A, Biasucci LM, Abbate A (2004) Female gender, myocardial remodeling and cardiac failure: are women protected from increased myocardiocyte apoptosis? Ital Heart J 5:498–504PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Melissa R. Dent
    • 1
  • Paramjit S. Tappia
    • 1
    • 2
  • Naranjan S. Dhalla
    • 1
    Email author
  1. 1.Department of Physiology, Faculty of Medicine, Institute of Cardiovascular SciencesSt. Boniface General Hospital Research CentreWinnipegCanada
  2. 2.Department of Human Nutritional Sciences, Faculty of Human EcologyUniversity of ManitobaWinnipegCanada

Personalised recommendations